Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Ingrid Binswanger to Adolescent

This is a "connection" page, showing publications Ingrid Binswanger has written about Adolescent.

 
Connection Strength
  
 
 
0.755
  
  1. Pytell JD, Christine PJ, LeMasters K, Rockhill KM, Black JC, Dart RC, Binswanger IA. Comparison of heroin and fentanyl use in US nationally representative surveys. Addict Sci Clin Pract. 2025 Feb 11; 20(1):13.
    View in: PubMed
    Score: 0.059
  2. Binswanger IA, Nguyen AP, Morenoff JD, Xu S, Harding DJ. The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study. Addiction. 2020 12; 115(12):2329-2338.
    View in: PubMed
    Score: 0.042
  3. Nguyen AP, Glanz JM, Narwaney KJ, Binswanger IA. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults. JAMA Netw Open. 2020 03 02; 3(3):e201018.
    View in: PubMed
    Score: 0.042
  4. Moore A, Cox-Martin M, Dempsey AF, Berenbaum Szanton K, Binswanger IA. HPV Vaccination in Correctional Care: Knowledge, Attitudes, and Barriers Among Incarcerated Women. J Correct Health Care. 2019 07; 25(3):219-230.
    View in: PubMed
    Score: 0.040
  5. Binswanger IA, Carroll NM, Ahmedani BK, Campbell CI, Haller IV, Hechter RC, McNeely J, Yarborough BJH, Kline-Simon AH, Satre DD, Weisner C, Lapham GT. The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Subst Abus. 2019; 40(3):292-301.
    View in: PubMed
    Score: 0.039
  6. Lapham GT, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller IV, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7?US health systems. Subst Abus. 2019; 40(3):268-277.
    View in: PubMed
    Score: 0.039
  7. Winkelman TNA, Chang VW, Binswanger IA. Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use. JAMA Netw Open. 2018 07 06; 1(3):e180558.
    View in: PubMed
    Score: 0.037
  8. Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 10; 33(10):1646-1653.
    View in: PubMed
    Score: 0.036
  9. Binswanger IA, Blatchford PJ, Forsyth SJ, Stern MF, Kinner SA. Epidemiology of Infectious Disease-Related Death After Release from Prison, Washington State, United States, and Queensland, Australia: A Cohort Study. Public Health Rep. 2016 Jul-Aug; 131(4):574-82.
    View in: PubMed
    Score: 0.032
  10. Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA. Naloxone Administration in US Emergency Departments, 2000-2011. J Med Toxicol. 2016 06; 12(2):148-56.
    View in: PubMed
    Score: 0.032
  11. Binswanger IA, Glanz JM. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice. Subst Abus. 2015; 36(2):141-3.
    View in: PubMed
    Score: 0.029
  12. Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013 Nov 05; 159(9):592-600.
    View in: PubMed
    Score: 0.027
  13. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 01; 131(3):263-70.
    View in: PubMed
    Score: 0.025
  14. Calcaterra S, Binswanger IA. National trends in psychostimulant-related deaths: 1999-2009. Subst Abus. 2013; 34(2):129-36.
    View in: PubMed
    Score: 0.025
  15. Binswanger IA, Krueger PM, Steiner JF. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health. 2009 Nov; 63(11):912-9.
    View in: PubMed
    Score: 0.020
  16. Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, Koepsell TD. Release from prison--a high risk of death for former inmates. N Engl J Med. 2007 Jan 11; 356(2):157-65.
    View in: PubMed
    Score: 0.017
  17. Metz VE, Palzes VA, Binswanger IA, Altschuler A, Poulsen MN, Ahmedani BK, Andrade SE, Clark RE, Hechter RC, Horberg MA, Sanchez K, Bailey SR, Stephens KA, Rubinstein AL, Campbell CI. Risks for Adverse Events by Sex and Age After Prescription Opioid Dose Reduction: A Secondary Analysis Across 8 U.S. Health Systems. Am J Prev Med. 2025 Dec; 69(6):108085.
    View in: PubMed
    Score: 0.015
  18. Jurecka C, Adams J, Padmanabhan P, Glanz J, Christine P, Guan X, Kline D, Binswanger I, Barocas J. Implementation of a Statewide Fentanyl Possession Law and Opioid-Related Overdose Deaths. JAMA Health Forum. 2025 Aug 01; 6(8):e252654.
    View in: PubMed
    Score: 0.015
  19. Christine PJ, Goldman AL, Morgan JR, Yan S, Chatterjee A, Bettano AL, Binswanger IA, LaRochelle MR. Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosis. JAMA Health Forum. 2024 Jul 05; 5(7):e242014.
    View in: PubMed
    Score: 0.014
  20. Braciszewski JM, Idu AE, Yarborough BJH, Stumbo SP, Bobb JF, Bradley KA, Rossom RC, Murphy MT, Binswanger IA, Campbell CI, Glass JE, Matson TE, Lapham GT, Loree AM, Barbosa-Leiker C, Hatch MA, Tsui JI, Arnsten JH, Stotts A, Horigian V, Hutcheson R, Bart G, Saxon AJ, Thakral M, Ling Grant D, Pflugeisen CM, Usaga I, Madziwa LT, Silva A, Boudreau DM. Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder. Psychiatr Serv. 2022 12 01; 73(12):1330-1337.
    View in: PubMed
    Score: 0.012
  21. Carrell DS, Cronkite DJ, Shea M, Oliver M, Luce C, Matson TE, Bobb JF, Hsu C, Binswanger IA, Browne KC, Saxon AJ, McCormack J, Jelstrom E, Ghitza UE, Campbell CI, Bradley KA, Lapham GT. Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods. Subst Abus. 2022; 43(1):917-924.
    View in: PubMed
    Score: 0.012
  22. Wagner NM, Binswanger IA, Shetterly SM, Rinehart DJ, Wain KF, Hopfer C, Glanz JM. Development and validation of a prediction model for opioid use disorder among youth. Drug Alcohol Depend. 2021 10 01; 227:108980.
    View in: PubMed
    Score: 0.012
  23. Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems. Addict Sci Clin Pract. 2021 07 07; 16(1):46.
    View in: PubMed
    Score: 0.011
  24. Matson TE, Carrell DS, Bobb JF, Cronkite DJ, Oliver MM, Luce C, Ghitza UE, Hsu CW, Campbell CI, Browne KC, Binswanger IA, Saxon AJ, Bradley KA, Lapham GT. Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State. JAMA Netw Open. 2021 05 03; 4(5):e219375.
    View in: PubMed
    Score: 0.011
  25. Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020 02 01; 207:107732.
    View in: PubMed
    Score: 0.010
  26. Hechter RC, Horberg MA, Weisner C, Campbell CI, Contreras R, Chen LH, Yarborough BJH, Lapham GT, Haller IV, Ahmedani BK, Binswanger IA, Kline-Simon AH, Satre DD. Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis. Subst Abus. 2019; 40(3):302-310.
    View in: PubMed
    Score: 0.010
  27. Kline-Simon AH, Stumbo SP, Campbell CI, Binswanger IA, Weisner C, Haller IV, Hechter RC, Ahmedani BK, Lapham GT, Loree AM, Sterling SA, Yarborough BJH. Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings. Subst Abus. 2019; 40(3):278-284.
    View in: PubMed
    Score: 0.010
  28. Loree AM, Yeh HH, Satre DD, Kline-Simon AH, Yarborough BJH, Haller IV, Campbell CI, Lapham GT, Hechter RC, Binswanger IA, Weisner C, Ahmedani BK. Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems. Subst Abus. 2019; 40(3):311-317.
    View in: PubMed
    Score: 0.010
  29. Weisner C, Campbell CI, Altschuler A, Yarborough BJH, Lapham GT, Binswanger IA, Hechter RC, Ahmedani BK, Haller IV, Sterling SA, McCarty D, Satre DD, Kline-Simon AH. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015. Subst Abus. 2019; 40(3):318-327.
    View in: PubMed
    Score: 0.010
  30. Campbell CI, Weisner C, Binswanger IA, Lapham GT, Ahmedani BK, Yarborough BJH, Haller IV, Altschuler A, Hechter RC, Loree AM, Kline-Simon AH. Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems. Subst Abus. 2019; 40(3):328-334.
    View in: PubMed
    Score: 0.010
  31. Calcaterra SL, Scarbro S, Hull ML, Forber AD, Binswanger IA, Colborn KL. Prediction of Future Chronic Opioid Use Among Hospitalized Patients. J Gen Intern Med. 2018 06; 33(6):898-905.
    View in: PubMed
    Score: 0.009
  32. Winkelman TNA, Frank JW, Binswanger IA, Pinals DA. Health Conditions and Racial Differences Among Justice-Involved Adolescents, 2009 to 2014. Acad Pediatr. 2017 Sep - Oct; 17(7):723-731.
    View in: PubMed
    Score: 0.009
  33. Frank JW, Binswanger IA, Calcaterra SL, Brenner LA, Levy C. Non-medical use of prescription pain medications and increased emergency department utilization: Results of a national survey. Drug Alcohol Depend. 2015 Dec 01; 157:150-7.
    View in: PubMed
    Score: 0.008
  34. Gaskin GL, Glanz JM, Binswanger IA, Anoshiravani A. Immunization Coverage Among Juvenile Justice Detainees. J Correct Health Care. 2015 Jul; 21(3):265-75.
    View in: PubMed
    Score: 0.008
  35. Lim S, Seligson AL, Parvez FM, Luther CW, Mavinkurve MP, Binswanger IA, Kerker BD. Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001-2005. Am J Epidemiol. 2012 Mar 15; 175(6):519-26.
    View in: PubMed
    Score: 0.006
  36. Loeb DF, Lee RS, Binswanger IA, Ellison MC, Aagaard EM. Patient, resident physician, and visit factors associated with documentation of sexual history in the outpatient setting. J Gen Intern Med. 2011 Aug; 26(8):887-93.
    View in: PubMed
    Score: 0.006
  37. Merrall EL, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, Hutchinson SJ, Bird SM. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010 Sep; 105(9):1545-54.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)